Although the number of fibroblasts in the human samples was limited, we corroborated some in vitro data, including increased expression of CXCL1 in the KRASG12D-driven versus non–KRAS-driven lung cancer samples (Supplemental Figure 7A). This evidence concerns the gene KRAS and lung cancer.